From: Increased arterial stiffness parameters in panic disorder patients in long term treatment period
Patient with panic disorder (n = 25) | Control group (n = 25) | p | |
---|---|---|---|
Agea (years) | 34.8 ± 7.9 | 35.5 ± 7.5 | 0.756 |
Female genderb, n (%) | 19 (76) | 16 (64) | 0.355 |
Body surfaced areaa (m2) | 1.86 ± 0.26 | 1.80 ± 0.23 | 0.392 |
BDI scoresc | 17.8 ± 9.6 | 5.9 ± 5.2 | <0.001 |
BAI scoresc | 31.5 ± 13.8 | 6.3 ± 3.6 | <0.001 |
Antidepressant treatment | Paroxetine (n = 9) | ||
Escitalopram (n = 7) | |||
Sertraline (n = 5) | – | ||
Fluoxetine (n = 3) | |||
Fluvoxamine (n = 1) |